Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Construction in Progress (2014 - 2018)

Omnicell's (OMCL) quarterly Construction in Progress came in at $10.7 million in Q4 2018, up 9.1% year-over-year from $9.8 million in Q4 2017, and down 6.32% quarter-over-quarter from $11.4 million in Q3 2018.

Analysis

Omnicell (OMCL) Construction in Progress (2014 - 2018) Analysis & Trends

Omnicell (OMCL) has reported Construction in Progress for 5 consecutive years, with $10.7 million the latest figure, recorded in Q4 2018.

  • On a quarterly basis, Construction in Progress rose 9.1% year-over-year to $10.7 million in Q4 2018; TTM through Dec 2018 was $10.7 million, a 9.1% increase from a year earlier, with the FY2018 full-year figure at $10.7 million, up 9.1% from the prior year.
  • Construction in Progress was $10.7 million for Q4 2018 at Omnicell, down from $11.4 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $12.5 million in Q2 2018 and troughed at $1.5 million in Q4 2014.
  • A 5-year average of $7.6 million and a median of $7.5 million in 2016 frame the typical range for Construction in Progress.
  • Across the five-year window, Construction in Progress surged 137.39% in 2015 and increased 8.22% in 2017, its largest moves.
  • Over 5 years, Construction in Progress stood at $1.5 million in 2014, then jumped by 137.39% to $3.7 million in 2015, then jumped by 97.51% to $7.2 million in 2016, then jumped by 36.08% to $9.8 million in 2017, then advanced by 9.1% to $10.7 million in 2018.
  • The last three Construction in Progress figures came in at $10.7 million (Q4 2018), $11.4 million (Q3 2018), and $12.5 million (Q2 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 911.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn -
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 10.71 Mn
Sep 30, 2018 11.43 Mn
Jun 30, 2018 12.49 Mn
Mar 31, 2018 11.33 Mn
Dec 31, 2017 9.81 Mn
Sep 30, 2017 8.08 Mn
Jun 30, 2017 9.29 Mn
Mar 31, 2017 7.63 Mn
Dec 31, 2016 7.21 Mn
Sep 30, 2016 7.47 Mn
Jun 30, 2016 5.93 Mn
Mar 31, 2016 5.41 Mn
Dec 31, 2015 3.65 Mn
Sep 30, 2015 4.90 Mn
Jun 30, 2015 3.98 Mn
Dec 31, 2014 1.54 Mn